Today is the Worst GLP1s+ Will Ever Be GLP1s+ More effective (5% to 22% weight loss and on their way to 25%+) More expansive disease management (diabetes, obesity, CVD, CKD, OSA, and studied for more) Less frequent (2x per day to 1x week and on their way to 1x/month to 1x/year?) Additional effective options in orals are on their way Insurance Coverage Medicare adding coverage for CVD (hopefully more diseases on the way as labels expand) Medicaid added 5 states in just 2023 Federal government added all employees and family members in 2023 Commercial employer coverage increased by 35% in 2023, with more employers considering it The Treat and Reduce Obesity Act (TROA) has been introduced in Congress to encourage Medicare coverage Costs Zepbound, a more effective drug, launched ~20-30% cheaper than Wegovy, with a savings card that put it at just over 1/3rd of the price at the time
If you experienced prolonged vomiting after starting a GLP-1 drug, this warning which came after many patients were already harmed may be central to your legal claim
Real-Time Monitoring and Support One of the standout features of BodySites Semaglutide Weight Loss Program is its real-time patient monitoring
So people had decided they had lost enough or too much and they were done. Basically, if weight loss is your main health goal, you may find retatrutide works a little too well, and a less powerful drug or lifestyle changes may be better for you
Clinical research consistently shows that daily beetroot intake supports healthy blood pressure , with measurable effects seen within 24 weeks
